June 22, 2026 · Form 4 insider transaction
Patel Jeegar Pravinkumar sold 1,488 shares of Evommune, Inc. at $22.50 per share, a transaction worth $33.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.